RLAY
Relay Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$19.04
+0.16%Leverage
- Debt / equity
- 0.03x
- Net debt / equity
- -0.10x
- Debt / assets
- 0.03x
- Debt / EBITDA
- -0.11x
- Net debt / EBITDA
- 0.32x
Liquidity & coverage
- Current ratio
- 18.27x
- Quick ratio
- 18.27x
- Cash ratio
- 17.93x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $877.3M
Cash & dividend
- FCF / debt
- -6.92x
- Cash flow / debt
- -6.92x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026